131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment von D'Huyvetter, Matthias, De Vos, Jens, Xavier, Catarina, Pruszynski, Marek, Sterckx, Yann G.J., Massa, Sam, Raes, Geert, Caveliers, Vicky, Zalutsky, Michael R., Lahoutte, Tony, Devoogdt, Nick

Volltext

CD38 as theranostic target in oncology von Bocuzzi, Valentina, Bridoux, Jessica, Pirotte, Michelle, Withofs, Nadia, Hustinx, Roland, D'Huyvetter, Matthias, Caers, Jo, Marcion, Guillaume

Volltext

Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α‑Particle Therapy of Cancer von Pruszynski, Marek, D’Huyvetter, Matthias, Bruchertseifer, Frank, Morgenstern, Alfred, Lahoutte, Tony

Volltext

A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy von Vargas, Clarita Saldarriaga, Struelens, Lara, D'Huyvetter, Matthias, Caveliers, Vicky, Covens, Peter

Volltext

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma von Krasniqi, Ahmet, D'Huyvetter, Matthias, Xavier, Catarina, Van der Jeught, Kevin, Muyldermans, Serge, Van Der Heyden, José, Lahoutte, Tony, Tavernier, Jan, Devoogdt, Nick

Volltext

Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model von Ceuppens, Hannelore, Pombo Antunes, Ana Rita, Navarro, Laurent, Ertveldt, Thomas, Berdal, Marion, Nagachinta, Surasa, De Ridder, Kirsten, Lahoutte, Tony, Keyaerts, Marleen, Devoogdt, Nick, Goyvaerts, Cleo, D’Huyvetter, Matthias, Breckpot, Karine

Volltext

Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior von Dekempeneer, Yana, Bäck, Tom, Aneheim, Emma, Jensen, Holger, Puttemans, Janik, Xavier, Catarina, Keyaerts, Marleen, Palm, Stig, Albertsson, Per, Lahoutte, Tony, Caveliers, Vicky, Lindegren, Sture, D’Huyvetter, Matthias

Volltext

SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis von Put, Stéphanie, Schoonooghe, Steve, Devoogdt, Nick, Schurgers, Evelien, Avau, Anneleen, Mitera, Tania, D'Huyvetter, Matthias, De Baetselier, Patrick, Raes, Geert, Lahoutte, Tony, Matthys, Patrick

Volltext

Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases von Puttemans, Janik, Lahoutte, Tony, D'Huyvetter, Matthias, Devoogdt, Nick

Volltext

Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors von Bolli, Evangelia, D’Huyvetter, Matthias, Murgaski, Aleksandar, Berus, Danielle, Stangé, Geert, Clappaert, Emile J., Arnouk, Sana, Pombo Antunes, Ana Rita, Krasniqi, Ahmet, Lahoutte, Tony, Gonçalves, Amanda, Vuylsteke, Marnik, Raes, Geert, Devoogdt, Nick, Movahedi, Kiavash, Van Ginderachter, Jo A.

Volltext

Targeted α-Therapy Using 225 Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Mic... von Ertveldt, Thomas, Krasniqi, Ahmet, Ceuppens, Hannelore, Puttemans, Janik, Dekempeneer, Yana, Jonghe, Kevin De, Mey, Wout de, Lecocq, Quentin, Vlaeminck, Yannick De, Awad, Robin Maximilian, Goyvaerts, Cleo, Veirman, Kim De, Morgenstern, Alfred, Bruchertseifer, Frank, Keyaerts, Marleen, Devoogdt, Nick, D'Huyvetter, Matthias, Breckpot, Karine

Volltext

Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20 von Krasniqi, Ahmet, Bialkowska, Magdalena, Xavier, Catarina, Van der Jeught, Kevin, Muyldermans, Serge, Devoogdt, Nick, D’Huyvetter, Matthias

Volltext

Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology von Krasniqi, Ahmet, D'Huyvetter, Matthias, Devoogdt, Nick, Frejd, Fredrik Y, Sörensen, Jens, Orlova, Anna, Keyaerts, Marleen, Tolmachev, Vladimir

Volltext

Reshaping nanobodies for affinity purification on protein a von Crauwels, Maxine, Van Vaerenbergh, Nele, Kulaya, Neeme Benedict, Vincke, Cécile, D’Huyvetter, Matthias, Devoogdt, Nick, Muyldermans, Serge, Xavier, Catarina

Volltext

Evaluation of an Anti-HER2 Nanobody Labeled with 225 Ac for Targeted α-Particle Therapy of Cancer von Pruszynski, Marek, D'Huyvetter, Matthias, Bruchertseifer, Frank, Morgenstern, Alfred, Lahoutte, Tony

Volltext

Phase I Trial of 131 I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients von D'Huyvetter, Matthias, Vos, Jens De, Caveliers, Vicky, Vaneycken, Ilse, Heemskerk, Johannes, Duhoux, Francois P, Fontaine, Christel, Vanhoeij, Marian, Windhorst, Albert D, Aa, Frank van der, Hendrikse, N Harry, Eersels, Jos L E, Everaert, Hendrik, Gykiere, Pieterjan, Devoogdt, Nick, Raes, Geert, Lahoutte, Tony, Keyaerts, Marleen

Volltext

Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer von Dekempeneer, Yana, Caveliers, Vicky, Ooms, Maarten, Maertens, Dominic, Gysemans, Mireille, Lahoutte, Tony, Xavier, Catarina, Lecocq, Quentin, Maes, Ken, Covens, Peter, Miller, Brian W, Bruchertseifer, Frank, Morgenstern, Alfred, Cardinaels, Thomas, D’Huyvetter, Matthias

Volltext

Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α von Dekempeneer, Yana, Massa, Sam, Santens, Francis, Navarro, Laurent, Berdal, Marion, Lucero, Melissa Miranda, Pombo Antunes, Ana Rita, Lahoutte, Tony, Van Ginderachter, Jo A, Devoogdt, Nick, D'Huyvetter, Matthias

Volltext

Correction to: CD38 as theranostic target in oncology von Bocuzzi, Valentina, Bridoux, Jessica, Pirotte, Michelle, Withofs, Nadia, Hustinx, Roland, D'Huyvetter, Matthias, Caers, Jo, Marcion, Guillaume

Volltext

Immuno-imaging using nanobodies von Vaneycken, Ilse, D’huyvetter, Matthias, Hernot, Sophie, De Vos, Jens, Xavier, Catarina, Devoogdt, Nick, Caveliers, Vicky, Lahoutte, Tony

Volltext